Cart
sales@molnova.com
5-phenylthieno[2,3-d]pyrimidin-4-amine
CAS No. 195193-10-3
5-phenylthieno[2,3-d]pyrimidin-4-amine( —— )
Catalog No. M28408 CAS No. 195193-10-3
5-phenylthieno[2,3-d]pyrimidin-4-amine is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 57 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 131 | Get Quote |
|
| 25MG | 224 | Get Quote |
|
| 50MG | 336 | Get Quote |
|
| 100MG | 503 | Get Quote |
|
| 500MG | 1107 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name5-phenylthieno[2,3-d]pyrimidin-4-amine
-
NoteResearch use only, not for human use.
-
Brief Description5-phenylthieno[2,3-d]pyrimidin-4-amine is a chemical compound.
-
Description5-phenylthieno[2,3-d]pyrimidin-4-amine is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetALK
-
RecptorRARγ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number195193-10-3
-
Formula Weight227.285
-
Molecular FormulaC12H9N3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNc1ncnc2scc(-c3ccccc3)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M I Dawson, et al. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition. Int J Cancer. 2001 Jan 1;91(1):8-21.
molnova catalog
related products
-
SB-505124 hydrochlor...
SB-505124 hydrochloride (SB505124 hydrochloride) is an orally available, selective and potent inhibitor of TGF-β type I receptors (ALK4, ALK5, ALK7) with IC50 values of 129 nM and 47 nM for ALK4 and ALK5, respectively.
-
Ascrinvacumab
Ascrinvacumab (PF-03446962) is a highly humanized IgG2 monoclonal antibody against ALK-1 with a Kd value of 7 nM for human ALK1.
-
LDK378 dihydrochlori...
Ceritinib dihydrochloride is a selective, orally bioavailable and ATP-competitive inhibitor of ALK tyrosine kinase(IC50 of 200 pM), and also inhibits IGF-1R, InsR, and STK22D (IC50 values of 8, 7, and 23 nM, respectively).
